Raymond James Financial Services Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$158M Buy
491,255
+11,930
+2% +$3.9M 0.21% 99
2024
Q2
$150M Buy
479,325
+11,589
+2% +$3.4M 0.21% 92
2024
Q1
$133M Buy
467,736
+13,820
+3% +$4.04M 0.2% 101
2023
Q4
$131M Buy
453,916
+8,305
+2% +$2.26M 0.21% 97
2023
Q3
$120M Buy
445,611
+3,009
+0.7% +$751K 0.22% 102
2023
Q2
$98.3M Buy
442,602
+7,317
+2% +$1.7M 0.17% 133
2023
Q1
$105M Buy
435,285
+8,465
+2% +$2.08M 0.2% 108
2022
Q4
$112M Sell
426,820
-27,082
-6% -$7.26M 0.23% 91
2022
Q3
$102M Sell
453,902
-23,859
-5% -$5.78M 0.23% 96
2022
Q2
$116M Sell
477,761
-5,427
-1% -$1.33M 0.25% 85
2022
Q1
$117M Buy
483,188
+23,797
+5% +$5.47M 0.22% 95
2021
Q4
$103M Buy
459,391
+14,968
+3% +$3.16M 0.19% 114
2021
Q3
$94.5M Buy
444,423
+13,692
+3% +$3.15M 0.19% 109
2021
Q2
$105M Sell
430,731
-379,393
-47% -$93.3M 0.21% 94
2021
Q1
$202M Buy
810,124
+69,402
+9% +$16.6M 0.45% 43
2020
Q4
$170M Buy
740,722
+3,016
+0.4% +$695K 0.43% 48
2020
Q3
$188M Buy
737,706
+92,261
+14% +$22.9M 0.54% 32
2020
Q2
$152M Buy
645,445
+384,997
+148% +$87.8M 0.48% 37
2020
Q1
$52.8M Buy
260,448
+18,545
+8% +$4.05M 0.23% 98
2019
Q4
$58.3M Buy
241,903
+16,394
+7% +$3.61M 0.19% 116
2019
Q3
$43.6M Sell
225,509
-9,968
-4% -$1.91M 0.16% 134
2019
Q2
$43.4M Sell
235,477
-2,155
-0.9% -$386K 0.17% 125
2019
Q1
$45.1M Sell
237,632
-1,842
-0.8% -$352K 0.19% 114
2018
Q4
$46.6M Buy
239,474
+6,633
+3% +$1.29M 0.25% 82
2018
Q3
$48.3M Buy
232,841
+14,251
+7% +$2.81M 0.22% 99
2018
Q2
$40.4M Sell
218,590
-414
-0.2% -$73.2K 0.21% 104
2018
Q1
$37.3M Sell
219,004
-6,151
-3% -$1.13M 0.21% 102
2017
Q4
$39.2M Buy
225,155
+8,135
+4% +$1.44M 0.24% 89
2017
Q3
$40.5M Buy
217,020
+28,988
+15% +$5.14M 0.26% 80
2017
Q2
$32.4M Buy
188,032
+28,493
+18% +$4.63M 0.22% 98
2017
Q1
$26.2M Buy
159,539
+13,482
+9% +$2.24M 0.2% 113
2016
Q4
$21.4M Buy
146,057
+7,579
+5% +$1.14M 0.18% 128
2016
Q3
$23.1M Buy
138,478
+20,177
+17% +$3.41M 0.21% 119
2016
Q2
$18M Buy
118,301
+9,916
+9% +$1.54M 0.17% 144
2016
Q1
$16.3M Buy
108,385
+7,952
+8% +$1.18M 0.19% 134
2015
Q4
$16.3M Buy
100,433
+15,982
+19% +$2.51M 0.19% 132
2015
Q3
$11.7M Buy
84,451
+62,055
+277% +$9.78M 0.2% 127
2015
Q2
$3.44M Buy
22,396
+10,568
+89% +$1.69M 0.25% 103
2015
Q1
$1.89M Buy
11,828
+364
+3% +$57.3K 0.09% 245
2014
Q4
$1.83M Buy
11,464
+114
+1% +$17.8K 0.09% 245
2014
Q3
$1.59M Sell
11,350
-186
-2% -$24.3K 0.09% 260
2014
Q2
$1.37M Sell
11,536
-4,298
-27% -$498K 0.08% 269
2014
Q1
$1.95M Buy
15,834
+278
+2% +$33.7K 0.12% 218
2013
Q4
$1.77M Buy
15,556
+4,458
+40% +$507K 0.11% 220
2013
Q3
$1.24M Buy
+11,098
New +$1.2M 0.08% 269

Other funds holding AMGN

Raymond James Financial Services Advisors's AMGN Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Amgen (AMGN) stake by 2.5% in Q3 2024, buying an estimated $3.9M and bringing the position to 491,255 shares worth $158M. The position accounts for 0.21% of the portfolio, ranked #99.

Raymond James Financial Services Advisors first reported a position in AMGN in Q3 2013 and has held it in 45 quarters since. The position peaked at $202M in Q1 2021. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Raymond James Financial Services Advisors held 491,255 shares of Amgen worth $158M as of Q3 2024.
  • Raymond James Financial Services Advisors bought 11,930 Amgen shares in Q3 2024, an estimated $3.9M.
  • Amgen made up 0.21% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #99 holding.
  • Raymond James Financial Services Advisors first reported a position in Amgen in Q3 2013 and has held it in 45 quarters since.
  • Raymond James Financial Services Advisors's Amgen position peaked at $202M in Q1 2021.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.